(ethylene diamine tetra-acetic acid)
Intravenous EDTA (ethylene diamine tetra-acetic acid). EDTA chelation therapy is primarily prescribed for the removal of heavy (and light) metals, especially mercury, lead, aluminum, radioactive isotopes, as well as plaque build-up on artery walls and heart capillaries, de-calcification of the pituitary gland (from fluoride), and more. These unwanted metals interfere with enzyme function, nerve and brain function, heart and lung function, skin health, hair growth, immunities, mood, and tend to promote free radical damage.
EDTA Chelation Therapy is an intravenous treatment that not only rids the body of potentially deadly toxins, but also restores good circulation to bodily tissues, while removing plaque along arterial walls. It has been proven to effectively treat atherosclerosis (hardening of the arteries) and gangrene, and can dramatically improve the quality of life for patients with arthritis, lupus, Scleroderma, and failing memory.
At BSI, we administer EDTA via vitamin C IV infusion, and occasionally add DMSO to increase effectiveness. Depending on the disease and its severity, a patient may need between 3 and 10 infusions to achieve full healing. The patient is given a capsule of colloidal trace minerals to replace those removed through chelation.
Initially introduced in 1914 to remove mercury from coal miners, the U.S. Food and Drug Administration has approved the use of chelation therapy with EDTA for treatment.
EDTA IV therapy shows nearly instantaneous and powerful effects on the body. An IV session usually lasts between 45 to 90 minutes, during which time between 25 to 50 mg of EDTA (plus vitamin C and other nutrients) are administered. The number of treatments necessary depends on the individual’s condition. EDTA can also be administered in low doses as preventative measure.
Most patients appear visibly younger, experience more stamina and energy and see their disease symptoms disappear.
Potential benefits of BSI IV chelation: